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Introduction i Results Discussion
Alzheimer’s Disease (AD) is the most common form of dementia 
and one of the most prominent challenges of precision healthcare is 
early identification of AD. To combat this issue, we plan to implement a 
method to use machine learning and deep learning to predict 
Alzheimer’s Disease. Through the use of post-mortum frontal cortex 
proteomic expression data, we have constructed a strong baseline for 
this type of work into the future.
While Learning methods for AD have already been developed 
using MRI and RNA in blood this is the first use of one using tissue 
data. Given the expensiveness of performing MRI and the lack of data 
for AD RNA in blood, this model is less expensive and has more data to 
train with, respectively. These optimizations will stand during transitions 
to other -omics data, types of tissue, and time of affliction.
Methods
Combinations of Feature Selection Methods and Machine/Deep 
Learning Methods were used to find the best way to identify AD.
Feature Selection Methods
K-Best (Control) -  Chooses top proteins only
MRMR -  Groups proteins first and chooses the best among a group
Learning Methods
Artificial Neural Network (ANNC), Gaussian Naive Bayes (GaussNB), 
Gradient Boosting Machine (GBM), K-Nearest Neighbors (KNear), 
Random Forest (Randforest), Support Vector Machine (SVM)
















Figure 2. R O C  C urve fo r Selection+Learning 
Combinations Across Testing-Training ratios
Second-stage RO C Curve, training-testing ratios are used 
for each combination. Specific ratios used are specified 
in Column Four in Table 1. The first iteration o f  ROC 
Curve goes by ratios o f  50% testing to 10% testing in 
steps o f  10% (I.e 50%,40%,30%,20%,10%.) The second 
stage uses the most performant value o f  each 
combination from first-stage and then increments by 2% 
twice in both directions. For example, i f  the value is 30% 
for MRM R+GaussNB then the values for the second- 
stage RO C Curve Testing ratios are 
26%,28%,30%,32%,34%.
Prediction precision using K-Best selection 
100 K-Best features
Prediction precision using MRMR selection 
100 MRMR features
Figure 1. W ork flow  Visualization for Feature+Learning Testing.
ANNC GaussNB GBM KnearRandforest SVM 
Machine learning methods
ANNC GaussNB GBM KnearRandforest SVM 
Machine learning methods
Figures 3 Accuracy P ro file  across Selection+Learning Combinations
Optimization o f  Feature+Learning method is performed with 100 shuffles and then tested using two-steps o f  ROC-Curves (see 
Figure 2.). A ll Machine Learning and Feature Selection methods were created using Sci-Kit Learn in Python 3.8.3. The Artificial 
Binary Neural Network Classifier (A N N C ) was created using Pytorch in Python 3.8.3.
Violin and Box plots representing the overall profile o f  each combination’s accuracy outcomes split into K-Best Selection (Left) 
and M R M R  Selection (Right). Each profile is across 100 runs using a shuffled samples for each run.
♦  Despite high accuracy scores some models might have been fit too 
closely to data and may not perform well cross-cohort.
♦  Taking into account the risk of over-fitting, precision, and accuracy 
the most optimal combination from this group is MRMR+RF.
♦  Inclusion of a sophisticated in-house, multi-omics feature selection 
method could lead to a better selection of proteins to train the 
Learning Models on.
♦  Other parameters such as amount of proteins used in the sets, 
along with further refinement of the neural network used could lead 
to different results.
Table 1. Accuracy Testing Results
Optimal A vg  Accuracy obtained was obtained purely from performance alone. Evaluations o f
Selection+Learning
Combination





K-Best+ANNC 84.25% at 6% testing 84.19% 9.54%
K-Best+GaussNB 77.77% at 12% testing 80.06% 8.18%
K-Best+GBM 84.89% at 24% testing 83.20% 4.74%
K-Best+KNear 83.89% at 10% testing 80.35% 8.42%
K-Best+RF 87.61% at 16% training 86.47% 6.53%
K-Best+SVM 87.35% at 12% training 85.95% 7.65%
MRMR+ANNC 88.89% at 8% testing 89.5% 8.17%
MRMR+GaussNB 86.85% at 34% testing 86.47% 4.01%
MRMR+GBM 87.75% at 6% testing 86.72% 8.82%
MRMR+KNear 90.13% at 8% testing 88.47% 7.49%
MRMR+RF 88.94% at 18% testing 87.35% 4.66%
MRMR+SVM 93.25% at 6% testing 91.32% 6.88%
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over-fitting is not evaluated at this stage.
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